产品说明书
Ethidium bromide
 |
同义名 : | 溴化乙锭 ;EtBr;Homidium bromide |
| CAS号 : | 1239-45-8 | |
| 货号 : | A752777 | |
| 分子式 : | C21H20BrN3 | |
| 纯度 : | 95% | |
| 分子量 : | 394.308 | |
| MDL号 : | MFCD00011724 | |
| 存储条件： |
粉末 Keep in dark place,Inert atmosphere,Room temperature 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 25 mg/mL(63.4 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Ethidium Bromide (EtBr) is sometimes added to running buffer during the separation of DNA fragments by agarose gel electrophoresis. It is used because upon binding of the molecule to the DNA and illumination with a UV light source, the DNA banding pattern can be visualized. The mode of binding of EtBr is intercalation between the base pairs. This binding changes the charge, weight, conformation, and flexibility of the DNA molecule. The mobility of DNA was always less in the gels with EtBr. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02520076 | Type 1 Diabetes Mellitus | Phase 1 Phase 2 | Active, not recruiting | March 2020 | Canada, Alberta ... 展开 >> University of Alberta Edmonton, Alberta, Canada, T6G 2C8 收起 << |
| NCT03536611 | Atrial Fibrillation ... 展开 >> Coronary Artery Disease 收起 << | Phase 4 | Not yet recruiting | June 30, 2020 | - |
| NCT02853006 | Lung Cancer | Not Applicable | Recruiting | June 2019 | France ... 展开 >> UniversityHospitalGrenoble Recruiting La Tronche, France, 38700 Contact: Christian Brambilla, Professor +33686793466 CBrambilla@chu-grenoble.fr Contact: Hélène Sabbah-Guillaume 04 76 76 68 16 HSabbahguillaume@chu-grenoble.fr 收起 << |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.54mL 0.51mL 0.25mL |
12.68mL 2.54mL 1.27mL |
25.36mL 5.07mL 2.54mL |
